The odds ratio (OR) for HLA-A*02:07 was significantly increased in EBV+ cHL as compared to EBV− cHL (OR = 6.34, 95% CI = 2.33–17.28, p = 0.0003). This evidence concerns the gene HLA-A and classic Hodgkin lymphoma.